119 related articles for article (PubMed ID: 31441205)
1. Evaluation of D-dimer levels in aqueous humor of rabbit eyes with and without induced intraocular fibrin and fibrinolytic treatment.
Voelter K; Tappeiner C; Riond B; Nuss K; Bruetsch D; Pot SA
Vet Ophthalmol; 2020 Mar; 23(2):212-218. PubMed ID: 31441205
[TBL] [Abstract][Full Text] [Related]
2. Aqueous humor fibrinolytic activity in dogs with cataracts.
Escanilla N; Leiva M; Monreal L; Ríos J; Peña T
Vet Ophthalmol; 2013 Nov; 16(6):409-15. PubMed ID: 23240635
[TBL] [Abstract][Full Text] [Related]
3. Intraocular penetration of topical tissue plasminogen activator.
Lim JI; Fiscella R; Tessler H; Gagliano DA; Chaques-Alepuz V; Mohler MA
Arch Ophthalmol; 1991 May; 109(5):714-7. PubMed ID: 1902662
[TBL] [Abstract][Full Text] [Related]
4. Fibrinolytic Capacity of Desmoteplase Compared to Tissue Plasminogen Activator in Rabbit Eyes.
Voelter K; Tappeiner C; Klein K; Borel N; Bruetsch D; Laguna Sanz F; Pot SA
J Ocul Pharmacol Ther; 2019; 35(1):66-75. PubMed ID: 30376399
[TBL] [Abstract][Full Text] [Related]
5. Sonothrombolysis for intraocular fibrin formation in an animal model.
Yamashita T; Ohtsuka H; Arimura N; Sonoda S; Kato C; Ushimaru K; Hara N; Tachibana K; Sakamoto T
Ultrasound Med Biol; 2009 Nov; 35(11):1845-53. PubMed ID: 19699025
[TBL] [Abstract][Full Text] [Related]
6. Development of an in vitro fibrin clot model to evaluate fibrinolytic agents for wound care application.
Viennet C; Laurensou C; Goydadin AC; Faivre B; Muret P; Humbert P
J Wound Care; 2014 Feb; 23(2):66-7, 70, 72. PubMed ID: 24526082
[TBL] [Abstract][Full Text] [Related]
7. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
Eisenberg PR; Jaffe AS; Stump DC; Collen D; Bovill EG
Circulation; 1990 Oct; 82(4):1159-68. PubMed ID: 2119264
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal clearance of tissue plasminogen activator in the rabbit.
Jaffe GJ; Green GD; McKay BS; Hartz A; Williams GA
Arch Ophthalmol; 1988 Jul; 106(7):969-72. PubMed ID: 3134000
[TBL] [Abstract][Full Text] [Related]
9. Collagen shield delivery of tissue plasminogen activator: functional and pharmacokinetic studies of anterior segment delivery.
Murray TG; Jaffe GJ; McKay BS; Han DP; Burke JM; Abrams GW
Refract Corneal Surg; 1992; 8(1):44-8; discussion 48-53. PubMed ID: 1554639
[TBL] [Abstract][Full Text] [Related]
10. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
Weitz JI; Leslie B; Ginsberg J
J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
[TBL] [Abstract][Full Text] [Related]
11. Subconjunctival and topical application of recombinant tissue plasminogen activator in rabbits.
Reggi JR; Hida RY; Hida MM; Nishiwaki-Dantas MC; Suzuki H
Arq Bras Oftalmol; 2015; 78(1):6-9. PubMed ID: 25714529
[TBL] [Abstract][Full Text] [Related]
12. Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban.
Varin R; Mirshahi S; Mirshahi P; Klein C; Jamshedov J; Chidiac J; Perzborn E; Mirshahi M; Soria C; Soria J
Thromb Res; 2013 Mar; 131(3):e100-9. PubMed ID: 23313382
[TBL] [Abstract][Full Text] [Related]
13. Degradation of fibrinogen and cross-linked fibrin by human neutrophil elastase generates D-like fragments detected by ELISA but not latex D-dimer test.
Bach-Gansmo ET; Godal HC; Skjønsberg OH
Thromb Res; 1998 Nov; 92(3):125-34. PubMed ID: 9806364
[TBL] [Abstract][Full Text] [Related]
14. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
[TBL] [Abstract][Full Text] [Related]
15. Reactivity of D-dimer assays with the fibrinogen--fibrin split products generated by thrombolytic agents.
Amiral J; Minard F; Plassart V; Vissac AM; Chambrette B
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):525-30. PubMed ID: 2133230
[TBL] [Abstract][Full Text] [Related]
16. Fibrinoid reaction after lens extraction in rabbit eyes.
Ben Simon GJ; Kenet G; Spierer A
J Cataract Refract Surg; 2012 May; 38(5):890-3. PubMed ID: 22445910
[TBL] [Abstract][Full Text] [Related]
17. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
Konieczynska M; Fil K; Bazanek M; Undas A
Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
[TBL] [Abstract][Full Text] [Related]
18. Clot Formation in the Presence of Acetylsalicylic Acid Leads to Increased Lysis Rates Regardless of the Chosen Thrombolysis Strategy.
Roessler FC; Schumacher S; Sprenger A; Gärtner U; Al-Khaled M; Eggers J
J Vasc Res; 2016; 53(3-4):128-137. PubMed ID: 27710967
[TBL] [Abstract][Full Text] [Related]
19. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
[TBL] [Abstract][Full Text] [Related]
20. Clot penetration and retention by plasminogen activators promote fibrinolysis.
Marcos-Contreras OA; Ganguly K; Yamamoto A; Shlansky-Goldberg R; Cines DB; Muzykantov VR; Murciano JC
Biochem Pharmacol; 2013 Jan; 85(2):216-22. PubMed ID: 23098998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
